Intravesical Radiofrequency-Induced Chemohyperthermia for Carcinoma of the Urinary Bladder: A Retrospective Multicentre Study

about

Intravesical Radiofrequency-Induced Chemohyperthermia for Carcinoma of the Urinary Bladder: A Retrospective Multicentre Study

Item

http://www.wikidata.org/entity/Q58705075

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована в жовтні 2018

@uk

name

Intravesical Radiofrequency-In ...... etrospective Multicentre Study

@en

Intravesical Radiofrequency-In ...... etrospective Multicentre Study

@nl

type

Item

label

Intravesical Radiofrequency-In ...... etrospective Multicentre Study

@en

Intravesical Radiofrequency-In ...... etrospective Multicentre Study

@nl

prefLabel

Intravesical Radiofrequency-In ...... etrospective Multicentre Study

@en

Intravesical Radiofrequency-In ...... etrospective Multicentre Study

@nl

P1476

Intravesical Radiofrequency-In ...... etrospective Multicentre Study

@en

P2093

Amir Kajtazovic

http://www.w3.org/2001/XMLSchema#string

Benjamin Ayres

http://www.w3.org/2001/XMLSchema#string

F Johannes P van Valenberg

http://www.w3.org/2001/XMLSchema#string

Gerson Lüdecke

http://www.w3.org/2001/XMLSchema#string

Giorgio Canepa

http://www.w3.org/2001/XMLSchema#string

J Alfred Witjes

http://www.w3.org/2001/XMLSchema#string

Jill-Isabel Kilb

http://www.w3.org/2001/XMLSchema#string

Katja K H Aben

http://www.w3.org/2001/XMLSchema#string

Ofer Nativ

http://www.w3.org/2001/XMLSchema#string

Rami Issa

http://www.w3.org/2001/XMLSchema#string

P2860

Intravesical hyperthermia and mitomycin-C for carcinoma in situ of the urinary bladder: experience of the European Synergo working party

Management of carcinoma in situ of the bladder: best practice and recent developments

Bacillus Calmette-Guérin (BCG) Treatment Failures with Non-Muscle Invasive Bladder Cancer: A Data-Driven Definition for BCG Unresponsive Disease

The role of a combined regimen with intravesical chemotherapy and hyperthermia in the management of non-muscle-invasive bladder cancer: a systematic review.

SWOG S0353: Phase II trial of intravesical gemcitabine in patients with nonmuscle invasive bladder cancer and recurrence after 2 prior courses of intravesical bacillus Calmette-Guérin

Efficacy and safety of photodynamic therapy for recurrent, high grade nonmuscle invasive bladder cancer refractory or intolerant to bacille Calmette-Guérin immunotherapy.

Differences between local and review urinary cytology in diagnosis of bladder cancer. An interobserver multicenter analysis.

Carcinoma in situ.

Intravesical valrubicin in patients with bladder carcinoma in situ and contraindication to or failure after bacillus Calmette-Guérin.

Clinical trial design for the development of new therapies for nonmuscle-invasive bladder cancer: report of a Food and Drug Administration and American Urological Association public workshop.

P304

365-376

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3233/BLC-180187

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-10-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30417047

http://www.w3.org/2001/XMLSchema#string

P932

6218119

http://www.w3.org/2001/XMLSchema#string